CHARLES WYKOFF to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications CHARLES WYKOFF has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.079
-
Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER Data. Am J Ophthalmol. 2022 04; 236:12-19.
Score: 0.046
-
Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad. Am J Ophthalmol. 2016 09; 169:xiv-xvi.
Score: 0.032